GREENHEART GP (00094) announced its interim results for the six months ended June 30, 2025. Revenue from continuing operations reached HK$20.632 million, representing a 10.34% increase compared to the same period last year. Loss attributable to shareholders expanded to HK$122 million, widening by 29.7% year-on-year. Basic loss per share was HK$0.059.